For your Mental Health, stay away - werkgeversreview EDiscovery Analyst bij Merck

1,0
15 sep 2022
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

- You will find some good friends - Great diversity and Inclusion

Minpunten

- No promotion or growth. - Leads makes sure you understand that contractors are below Merck staff - Only 45 min of Lunchtime - No matter if you excel above and beyond, your work will not be recognized - Management does not know how to lead - Communication and comprehension are at the very minimum. ( You can talk to them but expect almost zero understanding on their part) - Sanctions are group based - Leads and management do Micromanagement - Some leads are disrespectful to you as individual - The lead lies to upper management and uses you as a scapegoat - Stressing environment - The system in place does not work - The leads follow you when you step out for bathroom breaks or personal phone calls - They want you to be a brainless puppet - You have to cover your @ss with the leads, everything you converse with them has to be documented for your own good

Ontdek andere reviews over Merck

5,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Excellent company to work with.

Minpunten

No cons encountered so far

4,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Minpunten

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle